Kirk O - Search Results

1

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.

Mansfeld M, Skrahina A, Shepherd L, Schultze A, Panteleev AM, Miller RF, Miro JM, Zeltina I, Tetradov S, Furrer H, Kirk O, Grzeszczuk A, Bolokadze N, Matteelli A, Post FA, Lundgren JD, Mocroft A, Efsen A, Podlekareva DN; TB:HIV study group in EuroCoord. Mansfeld M, et al. Among authors: kirk o. HIV Med. 2015 Oct;16(9):544-52. doi: 10.1111/hiv.12256. Epub 2015 May 11. HIV Med. 2015. PMID: 25959854 Free PMC article.

2

Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study Group.

Kirk O, Mocroft A, Katzenstein TL, Lazzarin A, Antunes F, Francioli P, Brettle RP, Parkin JM, Gonzales-Lahoz J, Lundgren JD. Kirk O, et al. AIDS. 1998 Oct 22;12(15):2031-9. doi: 10.1097/00002030-199815000-00015. AIDS. 1998. PMID: 9814872

3

Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.

Kirk O, Katzenstein TL, Gerstoft J, Mathiesen L, Nielsen H, Pedersen C, Lundgren JD. Kirk O, et al. AIDS. 1999 Jan 14;13(1):F9-16. doi: 10.1097/00002030-199901140-00002. AIDS. 1999. PMID: 10207539 Clinical Trial.

4

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzáles-Lahoz J, d'Arminio Monforte A, Proenca R, Phillips AN, Lundgren JD, Reiss P. Weverling GJ, et al. Among authors: kirk o. Lancet. 1999 Apr 17;353(9161):1293-8. doi: 10.1016/s0140-6736(99)03287-0. Lancet. 1999. PMID: 10218526

5

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.

Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B, Lundgren JD. Mocroft A, et al. Among authors: kirk o. AIDS. 1999 May 28;13(8):943-50. doi: 10.1097/00002030-199905280-00010. AIDS. 1999. PMID: 10371175

6

Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

Kirk O, Lundgren JD, Pedersen C, Nielsen H, Gerstoft J. Kirk O, et al. AIDS. 1999 Sep 10;13(13):1647-51. doi: 10.1097/00002030-199909100-00007. AIDS. 1999. PMID: 10509565

7

Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.

Jensen-Fangel S, Kirk O, Larsen L, Blaxhult A, Gerstoft J, Pedersen C, Black FT, Lundgren JD, Obel N. Jensen-Fangel S, et al. Among authors: kirk o. Scand J Infect Dis. 1999;31(5):489-93. doi: 10.1080/00365549950164021. Scand J Infect Dis. 1999. PMID: 10576129

8

Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.

Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, Clotet B. Paredes R, et al. Among authors: kirk o. Arch Intern Med. 2000 Apr 24;160(8):1123-32. doi: 10.1001/archinte.160.8.1123. Arch Intern Med. 2000. PMID: 10789605

9

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.

Katzenstein TL, Kirk O, Pedersen C, Lundgren JD, Nielsen H, Obel N, Nielsen C, Mathiesen LR, Gerstoft J. Katzenstein TL, et al. Among authors: kirk o. J Infect Dis. 2000 Sep;182(3):744-50. doi: 10.1086/315746. Epub 2000 Aug 3. J Infect Dis. 2000. PMID: 10950767 Clinical Trial.

10

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, Phillips AN. Kirk O, et al. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72. doi: 10.1164/ajrccm.162.3.9908018. Am J Respir Crit Care Med. 2000. PMID: 10988097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters